Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)

Key facts

Sponsor

University of Roma La Sapienza

Principal Investigator

Andrea M Isidori, MD, PhD

Dept. Experimental Medicine

Intervention

Plenadren(drug)

Enrollment

89 enrolled

Eligibility

18-80 years · All sexes

Timeline

2014 – 2016

Study locations (1)

• Department of Experimental Medicine, Rome, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Addison disease

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT06955286
  Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion
  Qifu Li

See all trials for Addison disease →